Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 2/20 | 0.47 |
| ▸ | ERN1 | O75460 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NSD2 | O96028 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30832900 | 1.00 | AR (0.47) | ARERN1HTTMAOAMAOB | |
| SCHEMBL3341120 | 0.83 | ALDH1A1 (0.55) | ERN1HTTMAOAMAOBALDH1A1 | |
| SCHEMBL21592065 | 0.82 | PTPRC (0.40) | ARERN1HTTALDH1A1HPGD | |
| SCHEMBL24195885 | 0.80 | PTPRC (0.39) | ARERN1ALDH1A1HPGDMAPK1 | |
| SCHEMBL129664 | 0.80 | CA1 (0.61) | ARHTTALDH1A1HPGDMCL1 | |
| SCHEMBL29662013 | 0.80 | CA1 (0.61) | ARHTTALDH1A1HPGDMCL1 | |
| SCHEMBL2724088 | 0.79 | RAB9A (0.52) | MAPTPOLBKMT2AALOX15SMN1; SMN2 | |
| SCHEMBL2724086 | 0.79 | LMNA (0.53) | HTTALDH1A1HPGDMAPK1KDM4E | |
| SCHEMBL11449959 | 0.78 | AR (0.47) | ARERN1HTTALDH1A1HPGD | |
| SCHEMBL23242473 | 0.78 | AR (0.47) | ARERN1HTTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250276962-A1 | CONTRACEPTIVE COMPOUNDS AND METHODS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2025-09-04 | — | — | US | disclosed |
| US-12281105-B2 | Contraceptive compounds and methods | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2025-04-22 | — | — | US | disclosed |
| US-20250114345-A1 | COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF | ONCOPIA THERAPEUTICS, INC. D/B/A/ SK LIFE SCIENCE LABS | 2025-04-10 | — | — | US | disclosed |
| WO-2025049994-A1 | COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF | ONCOPIA THERAPEUTICS, INC. D/B/A SK LIFE SCIENCE LABS (US) | 2025-03-06 | — | — | WO | disclosed |
| US-20240391928-A1 | COMPOSITIONS FOR THE TREATMENT OF FOOD AND CHEMICAL ADDICTION AND METHODS OF MAKING AND USING SAME | UNIV DUKE (US) | 2024-11-28 | — | — | US | disclosed |
| EP-4404926-A1 | COMPOSITIONS FOR THE TREATMENT OF FOOD AND CHEMICAL ADDICTION AND METHODS OF MAKING AND USING SAME | Duke University (US) | 2024-07-31 | — | — | EP | disclosed |
| CN-117881674-A | Contraceptive compounds and methods | 明尼苏达大学董事会 | 2024-04-12 | — | — | CN | disclosed |
| US-20240109872-A1 | CONTRACEPTIVE COMPOUNDS AND METHODS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2024-04-04 | — | — | US | disclosed |
| CN-116964044-A | Acetamido-phenyltetrazole derivatives and methods of use thereof | 希华医药有限公司 | 2023-10-27 | — | — | CN | disclosed |
| US-11780828-B2 | Contraceptive compounds and methods | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2023-10-10 | — | — | US | disclosed |
| US-7390803-B2 | Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity | MERCK & CO., INC. (US) | 2008-06-24 | — | — | US | disclosed |
| US-7390803-B2 | Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity | MERCK & CO., INC. (US) | 2008-06-24 | — | — | US | disclosed |
| EP-1534698-B1 | FLAVONOID COMPOUNDS AS THERAPEUTIC ANTIOXIDANTS | ROWETT RES INST (GB) | 2007-09-19 | — | — | EP | disclosed |
| US-20060137207-A1 | Flavonoid compounds as therapeutic antioxidants | ANTOXIS LIMITED (GB) | 2006-06-29 | — | — | US | disclosed |
| EP-1534698-A1 | FLAVONOID COMPOUNDS AS THERAPEUTIC ANTIOXIDANTS | The Rowett Research Institute (GB) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004007475-A1 | FLAVONOID COMPOUNDS AS THERAPEUTIC ANTIOXIDANTS | ROWETT RESEARCH INSTITUTE (GB) | 2004-01-22 | — | — | WO | disclosed |
| US-6552071-B2 | Wedelolactone and its synthesis for treating neurodegenerative diseases | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2003-04-22 | — | — | US | disclosed |
| EP-1237550-A2 | METHODS FOR TREATING CELL DEATH DISEASES AND INFLAMMATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2002-09-11 | — | — | EP | disclosed |
| US-20020049251-A1 | Methods for treating cell death diseases and inflammation | HARVARD COLLEGE, PRESIDENT AND FELLOWS | 2002-04-25 | — | — | US | disclosed |
| WO-2001041709-A2 | METHODS FOR TREATING CELL DEATH DISEASES AND INFLAMMATION | PRESIDENT AND FELLOWS OF HARWARD COLLEGE (US) | 2001-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250276962-A1 | CONTRACEPTIVE COMPOUNDS AND METHODS | CYP19A1, GNRHR, NR5A1 | AR 99/4885ERN1 1811/4885HTT 3208/4885 |
| US-11780828-B2 | Contraceptive compounds and methods | CYP19A1, GNRHR, NR5A1 | AR 99/4885ERN1 1811/4885HTT 3208/4885 |
| US-20020049251-A1 | Methods for treating cell death diseases and inflammation | CASP3, CASP9, CASP2 | AR 3261/4885ERN1 868/4885HTT 947/4885 |
| US-20240391928-A1 | COMPOSITIONS FOR THE TREATMENT OF FOOD AND CHEMICAL ADDICTION AND METHODS OF MAKING AND USING SAME | PNMT, DBH, COMT | AR 3178/4885ERN1 1146/4885HTT 320/4885 |
| US-20250114345-A1 | COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF | EP300, CREBBP, HDAC1 | AR 743/4885ERN1 2404/4885HTT 1351/4885 |
| US-20240109872-A1 | CONTRACEPTIVE COMPOUNDS AND METHODS | CYP19A1, GNRHR, NR5A1 | AR 99/4885ERN1 1811/4885HTT 3208/4885 |
| US-12281105-B2 | Contraceptive compounds and methods | CYP19A1, GNRHR, NR5A1 | AR 99/4885ERN1 1811/4885HTT 3208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.